Search

Misook Yu

Supervisory Patent Examiner (ID: 1022, Phone: (571)272-0839 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642, 1641
Total Applications
859
Issued Applications
261
Pending Applications
201
Abandoned Applications
403

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 620003 [patent_doc_number] => 07141435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP' [patent_app_type] => utility [patent_app_number] => 10/285408 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5870 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141435.pdf [firstpage_image] =>[orig_patent_app_number] => 10285408 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/285408
Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP Oct 31, 2002 Issued
Array ( [id] => 7024947 [patent_doc_number] => 20050019341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 10/494069 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16883 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019341.pdf [firstpage_image] =>[orig_patent_app_number] => 10494069 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/494069
Tumor antigen Oct 28, 2002 Abandoned
Array ( [id] => 672037 [patent_doc_number] => 07091047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'Methods and kits for diagnosing tumorigenicity' [patent_app_type] => utility [patent_app_number] => 10/281160 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 14079 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091047.pdf [firstpage_image] =>[orig_patent_app_number] => 10281160 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/281160
Methods and kits for diagnosing tumorigenicity Oct 27, 2002 Issued
Array ( [id] => 6856130 [patent_doc_number] => 20030129631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Gene family with transformation modulating activity' [patent_app_type] => new [patent_app_number] => 10/273334 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16240 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129631.pdf [firstpage_image] =>[orig_patent_app_number] => 10273334 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/273334
Gene family with transformation modulating activity Oct 17, 2002 Abandoned
Array ( [id] => 7463070 [patent_doc_number] => 20040053228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same' [patent_app_type] => new [patent_app_number] => 10/148953 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6808 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053228.pdf [firstpage_image] =>[orig_patent_app_number] => 10148953 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/148953
Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same Oct 15, 2002 Abandoned
Array ( [id] => 6856128 [patent_doc_number] => 20030129629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Methods and compositions for the identification, assessment, prevention, and therapy of human cancers' [patent_app_type] => new [patent_app_number] => 10/272111 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50320 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129629.pdf [firstpage_image] =>[orig_patent_app_number] => 10272111 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/272111
Methods and compositions for the identification, assessment, prevention, and therapy of human cancers Oct 15, 2002 Abandoned
Array ( [id] => 536500 [patent_doc_number] => 07173112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Antibody to GALP and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/490917 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 14618 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173112.pdf [firstpage_image] =>[orig_patent_app_number] => 10490917 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/490917
Antibody to GALP and uses thereof Sep 24, 2002 Issued
Array ( [id] => 6692649 [patent_doc_number] => 20030040081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Galectin 9 and 10SV polynucleotides' [patent_app_type] => new [patent_app_number] => 10/235674 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16820 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040081.pdf [firstpage_image] =>[orig_patent_app_number] => 10235674 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/235674
Galectin 9 and 10SV polynucleotides Sep 5, 2002 Abandoned
Array ( [id] => 7175752 [patent_doc_number] => 20050123476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases' [patent_app_type] => utility [patent_app_number] => 10/488806 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39029 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123476.pdf [firstpage_image] =>[orig_patent_app_number] => 10488806 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/488806
Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases Sep 4, 2002 Abandoned
Array ( [id] => 6865179 [patent_doc_number] => 20030190705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Method of humanizing immune system molecules' [patent_app_type] => new [patent_app_number] => 10/230880 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29527 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190705.pdf [firstpage_image] =>[orig_patent_app_number] => 10230880 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/230880
Method of humanizing immune system molecules Aug 28, 2002 Abandoned
Array ( [id] => 6869914 [patent_doc_number] => 20030082603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Colon cancer marker' [patent_app_type] => new [patent_app_number] => 10/232803 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18244 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082603.pdf [firstpage_image] =>[orig_patent_app_number] => 10232803 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/232803
Colon cancer marker Aug 28, 2002 Abandoned
Array ( [id] => 6861653 [patent_doc_number] => 20030092661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => '88kDa tumorigenic growth factor and antagonists' [patent_app_type] => new [patent_app_number] => 10/218509 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20752 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092661.pdf [firstpage_image] =>[orig_patent_app_number] => 10218509 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/218509
88kDa tumorigenic growth factor and antagonists Aug 14, 2002 Abandoned
Array ( [id] => 6642592 [patent_doc_number] => 20030103976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Anti-fas antibodies' [patent_app_type] => new [patent_app_number] => 10/216484 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 68396 [patent_no_of_claims] => 119 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103976.pdf [firstpage_image] =>[orig_patent_app_number] => 10216484 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/216484
Anti-fas antibodies Aug 8, 2002 Abandoned
Array ( [id] => 330212 [patent_doc_number] => 07510707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'PAR, a novel marker gene for breast and prostate cancers' [patent_app_type] => utility [patent_app_number] => 10/178389 [patent_app_country] => US [patent_app_date] => 2002-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9204 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/510/07510707.pdf [firstpage_image] =>[orig_patent_app_number] => 10178389 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/178389
PAR, a novel marker gene for breast and prostate cancers Jun 23, 2002 Issued
Array ( [id] => 6783581 [patent_doc_number] => 20030065029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Agent for diagnosing and treating malignant tumors' [patent_app_type] => new [patent_app_number] => 10/174823 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5293 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065029.pdf [firstpage_image] =>[orig_patent_app_number] => 10174823 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/174823
Agent for diagnosing and treating malignant tumors Jun 19, 2002 Issued
Array ( [id] => 6735158 [patent_doc_number] => 20030012793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Compositions and methods for promoting tissue repair using heat shock proteins' [patent_app_type] => new [patent_app_number] => 10/174786 [patent_app_country] => US [patent_app_date] => 2002-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12946 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012793.pdf [firstpage_image] =>[orig_patent_app_number] => 10174786 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/174786
Compositions and methods for promoting tissue repair using heat shock proteins Jun 17, 2002 Abandoned
Array ( [id] => 6650884 [patent_doc_number] => 20030008370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => '13295 novel protein kinase molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 10/172088 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31529 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008370.pdf [firstpage_image] =>[orig_patent_app_number] => 10172088 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/172088
13295 novel protein kinase molecules and uses therefor Jun 12, 2002 Abandoned
Array ( [id] => 6735141 [patent_doc_number] => 20030012776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Nucleic acid and protein expressed thereby and their involvement in stress' [patent_app_type] => new [patent_app_number] => 10/164359 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12509 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012776.pdf [firstpage_image] =>[orig_patent_app_number] => 10164359 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/164359
Nucleic acid and protein expression thereby and their involvement in stress Jun 5, 2002 Issued
Array ( [id] => 5843023 [patent_doc_number] => 20060121457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Gfats as modifiers of the p53 pathway and methods of use' [patent_app_type] => utility [patent_app_number] => 10/480021 [patent_app_country] => US [patent_app_date] => 2002-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13395 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121457.pdf [firstpage_image] =>[orig_patent_app_number] => 10480021 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/480021
Gfats as modifiers of the p53 pathway and methods of use Jun 1, 2002 Abandoned
Array ( [id] => 4664432 [patent_doc_number] => 20080255339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities' [patent_app_type] => utility [patent_app_number] => 10/156920 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11663 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255339.pdf [firstpage_image] =>[orig_patent_app_number] => 10156920 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/156920
Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities May 28, 2002 Abandoned
Menu